Anthocyanins and Their Metabolites as Therapeutic Agents for Neurodegenerative Disease
Neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis (ALS), are characterized by the death of neurons within specific regions of the brain or spinal cord. While the etiology of many neurodegenerative diseases remains el...
Saved in:
Main Authors: | Aimee N. Winter (Author), Paula C. Bickford (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2019-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mithramycin, an Agent for Developing New Therapeutic Drugs for Neurodegenerative Diseases
by: Nobuhiro Osada, et al.
Published: (2013) -
Plant metabolite diosmin as the therapeutic agent in human diseases
by: Saad Mustafa, et al.
Published: (2022) -
The Signaling Pathways, and Therapeutic Targets of Antiviral Agents: Focusing on the Antiviral Approaches and Clinical Perspectives of Anthocyanins in the Management of Viral Diseases
by: Pardis Mohammadi Pour, et al.
Published: (2019) -
Navigating the Frontiers of Machine Learning in Neurodegenerative Disease Therapeutics
by: Yoonjeong Cha, et al.
Published: (2024) -
Variability of Anthocyanin Concentrations, Total Metabolite Contents and Antioxidant Activities in Adzuki Bean Cultivars
by: Kebede Taye Desta, et al.
Published: (2022)